Outset Medical Inc. (OM) News
Filter OM News Items
OM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OM News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest OM News From Around the Web
Below are the latest news stories about OUTSET MEDICAL INC that investors may wish to consider to help them evaluate OM as an investment opportunity.
Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceSAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 43rd annual J.P. Morgan Healthcare conference on Wednesday, January 15, 2025, at 8:15 a.m. Pacific time. A live and archived webcast of the presentation will be available on the “Investors” section of the Outset websit |
Outset Medical to pay down debt after raising nearly $300MStifel analyst Rick Wise said the financing, a combination of private stock placement and new loans, should help the dialysis device maker return to revenue growth. |
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional InvestorsSecures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt Reports Unaudited Fourth-Quarter Revenue of $29 million and 2024 Revenue of $113 million SAN JOSE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it has entered into a definitive securities purchase agreement for a priva |
Outset Medical to Present at the 2024 Stifel Healthcare ConferenceSAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2024 Stifel Healthcare conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time. A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://in |
Outset Medical (OM) Slipped on Earnings Miss and Reduced GuidanceColumbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter, the fund returned 9.15% while the benchmark, the Russell 2500 Growth Index, returned 6.99%. A strong market rally occurred throughout the quarter, and the Columbia Acorn Fund beat its benchmark […] |
Outset Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsOutset Medical ( NASDAQ:OM ) Third Quarter 2024 Results Key Financial Results Revenue: US$28.7m (down 5.6% from 3Q... |
Outset Medical Inc (OM) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ChallengesOutset Medical Inc (OM) reports strong recurring revenue growth and improved margins, while maintaining a conservative outlook for the future. |
Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue EstimatesOutset Medical (OM) delivered earnings and revenue surprises of 7.14% and 6.22%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |
Outset Medical Reports Third Quarter 2024 Financial ResultsSAN JOSE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2024. “During the quarter, we made significant progress, achieving sequential revenue growth, expanding the Tablo footprint in both the acute and home care settings, boosting gross margin compared to |
New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using TabloOutset Medical features patient experience posterpresentations at Kidney Week 2024 Consensus recommendations for use of catheters in home hemodialysis patients published in Kidney Medicine SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset″), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced two new research posters that demonstrate significant quality of life and menta |